Dysregulation of apoptosis as a mechanism of liver disease: An overview

Seminars in Liver Disease

Volumn 18, Issue 2, 1998, Pages 105-114

  Patel, Tushar ^a   Roberts, Lewis R ^a   Jones, Blake A ^a   Gores, Gregory J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Bcl 2; Death receptors; Fas; Mitochondria; Tumor necrosis factor

Indexed keywords

APOPTOSIS; ARTICLE; HUMAN; LIGAND BINDING; LIVER CELL; LIVER DISEASE; LIVER MITOCHONDRION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031902464     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007147     Document Type: Article

References (73)

1. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J Cell Sci 1994; 107:3569-3577
2. Kren BT, Trembley JH, Krajewski S, Behrens TW, Reed JC, Steer CJ. Modulation of apoptosis-associated genes bcl-2, bcl-x and bax during rat liver regeneration. Cell Growth Diff 1996;7: 1633-1642
3. Amicone L, Spagnoh F, Spath G, et al. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J 1997;16(3):495-503
4. Kerr JFR, Shrinkage necrosis: A distinct mode of cellular death. J Pathol 1971;105:13-20
5. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apopiosis. Int Rev Cytol 1980;68:251-306
6. Colucci WS. Apoptosis in the heart. N Eng J Med 1996;335: 1224-1226
7. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 1990;11:847-853
8. Feldman G, Liver apoptosis. J Hepatol 1997;26(suppl. 2):1-11
9. Fraser A, Evan G. A license to kill. Cell 1996;85:781-784
10. Patel T, Gores GJ, Kaufmann SH. The critical role of proteases during apoptosis. FASEB J 1996;10:587-597
11. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996;93:2239-2244
12. Steller H. Mechanism and genes of cellular suicide. Science 1995;267:1445-1449
13. Fadok VA, Voelker DR, Campbell PA, Henson PM. Exposure of phosphatidylscrine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-2216
14. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-1420
15. Hannun YA, Obeid LM. Ceramide: An intracellular signal for apoptosis. TIBS 1995;20:73-77
16. Kyriakis JM, Avruch J. Sounding the alarm - protein kinase cascades activated by stress and inflammation. J Biol Chem 1996; 271:24313-24316
17. Arora AS, Jones B, Patel T, Bronk S, Gores G. Ceramide induces hepatocyte cell death through disruption of mitochondrial function. Hepatology 1997;25(4):958-963
18. Fernandes-Alnemri T, Litwack G, Alnemri E. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 1994;269:30761-30764
19. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996;86(1): 147-157
20. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 1996;271: 16443-16446
21. Liu XS, Zou H, Slaughter C, Wang XD. DNA fragmentation factor. A heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89(2): 175-184
22. Oberhammer F, Wilson JW, Dive C, et al. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993;12:3679-3684
23. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284:555-556
24. Gavrieli Y, Sherman Y, Ben-Sasson SA Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
25. Patel T, Arora A, Gores GJ. A fluorometric assay for quantitating DNA strand breaks during apoptosis. Anal Biochem 1995;229: 229-235
26. Korsmeyer S. Bcl-2 initiates a new category of oncogenes; Regulators of cell death. Blood 1992;80:879-886
27. Reed J. Bcl-2 and the regulation of cell death. J Cell Biol 1994;124:1-6
28. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis Nature Medicine 1997;3:614-620
29. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132
30. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136
31. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ Hepatocytes in the bile duct ligated rat express Bcl-2: An adaptive mechanism to inhibit apoptosis by toxic bile salts. Am J Physiol 1997;272:G1587-G1593
32. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997;25(5):1077-1084
33. Tzung SP, Fausto N, Hockenhery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997;150(6):1985-1995
34. Shimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hypeiplasia in humans. Hepatology 1997;26:343-350
35. Schulte-Hermann R, Bursch W, Kraupp-Grasl B, Oberhammer F, Wagner A, Jirtle R. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Env Health Perspect 1993;101:87-90
36. Que F, Gores GJ. Apoptosis and the gastrointestinal system. In Kaufmann S, (ed): Advances in Pharmacology. New York: Academic Press; 1997: pp 409-428, vol 41
37. Stähelin BJ, Marti U, Solioz M, Zimmermann H, Reichen J. False positive staining in TUNEL assay is due to release of endogenous DNAse and inhibited by diethyl-pyrocarbonate (DEPC) in liver tissue (Abstract). Hepatology 1996;24:368A
38. Darzynkiewicz Z, Bruno S, Bino GD, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13(8):795-808
39. Rizzino A. Transforming growth factor B: Multiple effects on cell differentiation and extracellular matrices. Dev Biol 1988; 130:411-422
40. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 1992;89: 5408-5412
41. Oberhammer FA, Bursch W, Tiefenbacher R, et al. Apoptosis is induced by transforming growth factor β1 within 5 hours in regressing rat liver without significant fragmentation of the DNA. Hepatology 1993;18:1238-1246
42. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990;6:597-641
43. Russel WE, Coffey RJ, Oullette AJ, Moses HL, Type B transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988;85:5126-5130
44. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived TGF-b1. Cancer Res 1986;46:2330-2334
45. Oberhammer F, Nagy P, Tiefenbacher R, et al. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor beta 1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. Hepatology 1996;23(2):329-337
46. Mullauer L, Grasl-Kraupp B, Bursch W, Schulte-Hermann R. Transforming growth factor β1-induced cell death in prencoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Hepatology 1996;23:840-847
47. Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. J Gastroenterol Hepatol 1996;11:443-450
48. Shirai Y, Tamura SKS, Ito N, et al. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases Cancer 1994;73:2275-2279
49. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995;92: 2572-2576
50. Hasegawa K, Wang Z, Inagaki M, Carr BI. Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor b1 (TGF-b1). In Vitro Cell Dev Biol 1995;31:55-61
51. Inagaki M, Moustakas A, Lin HY, Lodish HF, Carr B. Growth inhibition by transforming growth factor b (TGF-b) type I is restored m TGF-b-resistant hepatoma cells after expression of TGF-b receptor type II cDNA. Proc Natl Acad Sci USA 1993; 90:5359-5363
52. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest. 1995;96:447-455
53. Gressner AM, Polzar B, Lahme B, Mannherz H-G. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor β. Hepatology 1996;23:571-581
54. Tachibana I, Imoto M, Adjei PN, et al. Overexpression of the TGF-beta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 1997; 99(10):2365-2374
55. Leist M, Gantner F, Kunstle G, et al. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 1996;2: 109-124
56. Ni R, Tomita Y, Matsuda K, et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Research 1994;215: 332-337
57. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809
58. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230
59. Adachi M, Suematsu S, Kondo T, et al. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genetics 1995;11(3):294-300
60. Heller RA, Krönke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994;126:5-9
61. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307-1316
62. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994;153:1778-1788
63. VanAntwerp DJ, Martin SJ, Kafri T, Green D, Verma I. Suppression of TNF-α-induced apoptosis by NF-kB Science 1996;274: 787-789
64. Beg AA, Baltimore D. An essential role for NF-kB in preventing TNF-a induced cell death. Science 1996;274:782-784
65. Wang C-Y, Mayo M, Baldwin A. TNF- and cancer therapyinduced apoptosis: Potentiation by inhibition of NF-kB. Science 1996;274:784-787
66. Diehl AM, Yin M, Fleckenstein J, et al. Tumor necrosis factoralpha induces c-jun during the regenerative response to liver injury. Am J Physiol 1994;267:G552-G561
67. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor - deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Nat Acad Sci USA 1997;94(4):1441-1446
68. Rouquet N, Pages JC, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis Curr Biol 1996;6(9):1192-1195
69. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 1996;184(5):2067-2072
70. Patel T, Gores GH. Apoptosis in liver transplantation: A mechanism contributing to immune modulation, preservation injury, neoplasia and viral disease. Liver Transplantation and Surgery 1998;4:42-50
71. Charlotte F, L'Hermine A, Martin N, et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144(3):460-465
72. Nakamura N, Shidoji Y, Moriwaki H, Muto Y. Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha. Biochemical & Biophysical Research Communications 1996;219:100-104
73. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Eng J Med 1996;334: 1561-1567